Disc Medicine (IRON) Cash from Investing Activities (2020 - 2026)

Disc Medicine (IRON) has 7 years of Cash from Investing Activities data on file, last reported at $58.3 million in Q1 2026.

• On a quarterly basis, Cash from Investing Activities rose 121.39% year-over-year to $58.3 million in Q1 2026; TTM through Mar 2026 was -$63.4 million, a 88.78% increase from a year earlier, with the FY2025 full-year figure at -$394.3 million, down 34.88% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $58.3 million, up from -$222.9 million in the prior quarter.
• Over the last five years, Cash from Investing Activities for IRON reached as high as $58.3 million in Q1 2026 and fell as low as -$272.6 million in Q1 2025.
• Historically, Cash from Investing Activities has averaged -$37.0 million across 5 years, with a median of -$29000.0 in 2023.
• Across the five-year window, Cash from Investing Activities sank 1831141.67% in 2024 and jumped 169.68% in 2025, its largest moves.
• Year by year, Cash from Investing Activities stood at -$12000.0 in 2022, then soared by 75.0% to -$3000.0 in 2023, then tumbled by 47433.33% to -$1.4 million in 2024, then tumbled by 15530.65% to -$222.9 million in 2025, then jumped by 126.16% to $58.3 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were $58.3 million in Q1 2026, -$222.9 million in Q4 2025, and $49.5 million in Q3 2025.